Copertina

Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shiru Cai, Shenglong Xu, Yan Zhao, Luo Zhang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Allergy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
di: Mu Xian, et al.
Pubblicazione: (2025)

Amphiregulin Mediates Epithelial Cell–Eosinophil Interactions and Amplifies Inflammation in Chronic Rhinosinusitis With Nasal Polyps
di: Limin Zhao, et al.
Pubblicazione: (2025)

Distinct Effects of Biological Treatments on Eosinophils and Neutrophils in Chronic Rhinosinusitis With Nasal Polyp Patients
di: Sharon Van Nevel, et al.
Pubblicazione: (2025)

Reply to: Real‐World Predictors of Dupilumab Prescription in Patients With Chronic Rhinosinusitis With Nasal Polyps
di: Christina Dorismond, et al.
Pubblicazione: (2025)

A Multicenter, Randomized, Controlled Clinical Trial on the Efficacy and Safety of Eucalyptol, Limonene, and Pinene Enteric Capsules in the Treatment of Chronic Rhinosinusitis With Nasal Polyps Postoperatively
di: Yutong Sima, et al.
Pubblicazione: (2025)

Lower Airway Conditions Contribute to the Prediction of Polyp Recurrence in Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma
di: Jiaxing Guo, et al.
Pubblicazione: (2026)

Comparative Transcriptomic Analysis of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps ( CRSwNP ) Using Nasal Tissue and Brushing Samples
di: Daiki Nakashima, et al.
Pubblicazione: (2026)

Type 2 Inflammation‐Biased Arachidonic Acid Metabolite Regulates Mucosal Remodeling of Chronic Rhinosinusitis With Nasal Polyps
di: Ying Li, et al.
Pubblicazione: (2026)

Letter to the Editor Regarding “Real‐World Predictors of Dupilumab Prescription in Patients With Chronic Rhinosinusitis With Nasal Polyps”
di: Yiheng Liu, et al.
Pubblicazione: (2025)

Prospective Real‐World Outcomes of Endoscopic Sinus Surgery and Dupilumab in Severe Chronic Rhinosinusitis With Nasal Polyps
di: Nirushan Narendran, et al.
Pubblicazione: (2026)

Postoperative Anti‐IgE Therapy for Chronic Rhinosinusitis With Nasal Polyps and Asthma: Efficacy and Prognostic Factors
di: Xiaomei Yang, et al.
Pubblicazione: (2025)

Downregulation of Tight Junction Protein MAGI1 by Interferon‐γ Contributes to Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps
di: Jing Song, et al.
Pubblicazione: (2024)

“Super‐Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps
di: P. E. Vonk, et al.
Pubblicazione: (2025)

Trends in Dupilumab Utilization for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
di: Daniel Xiao, et al.
Pubblicazione: (2024)

Asthma is Underdiagnosed and Often Uncontrolled in Preoperative Patients With Chronic Rhinosinusitis With Nasal Polyps
di: Emma Genberg, et al.
Pubblicazione: (2024)

Excessive Endoplasmic Reticulum Stress in B Cells Associates With the Local Immunoglobulin Production in Severe Type 2 Chronic Rhinosinusitis With Nasal Polyps
di: Yanran Huang, et al.
Pubblicazione: (2025)

Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
di: Eugenio De Corso, et al.
Pubblicazione: (2025)

Natural Killer Cell Dysfunction Causes Eosinophil Accumulation in Chronic Rhinosinusitis With Nasal Polyps
di: Yohei Sato, et al.
Pubblicazione: (2026)

Prevalence of Cystic Fibrosis Carrier Status in Chronic Rhinosinusitis Without Nasal Polyp
di: Do‐Yeon Cho, et al.
Pubblicazione: (2025)

Impact of Sinus Surgery on Bacteriome Composition in Patients With Chronic Rhinosinusitis With Nasal Polyps
di: Maria Vorobeva, et al.
Pubblicazione: (2025)

Almost Half of the Dupilumab‐Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year
di: Josje J. Otten, et al.
Pubblicazione: (2025)

Improvement of Mixed Inflammatory Environment in Nasal Secretions of Diffuse Type 2 Chronic Rhinosinusitis With Nasal Polyps Under Dupilumab
di: Fabio S. Ryser, et al.
Pubblicazione: (2026)

Acetylcholine From Solitary Chemosensory Cell, Not Neuron, Regulates Basal Cell Fate Driving Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
di: Bowen Zheng, et al.
Pubblicazione: (2025)

Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes
di: Alessandra Vultaggio, et al.
Pubblicazione: (2026)

Letter to the Editor Regarding “S100A9 Induces Tissue Remodeling of Human Nasal Epithelium in Chronic Rhinosinusitis With Nasal Polyp”
di: Yuqing Jiang, et al.
Pubblicazione: (2025)

Increased TRPV6 Potentiates Interleukin‐13 Signalling in Epithelial Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
di: Fuying Cheng, et al.
Pubblicazione: (2026)

Asthma Outcomes Following Early Versus Delayed Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
di: Jamie R. Oliver, et al.
Pubblicazione: (2025)

Distribution of Eosinophils Across Multiple Paranasal Sinuses Within Patients With Chronic Rhinosinusitis With Nasal Polyps
di: Aris I. Giotakis, et al.
Pubblicazione: (2026)

Response to the Letter Regarding “S100A9 Induces Tissue Remodeling of Human Nasal Epithelium in Chronic Rhinosinusitis With Nasal Polyp”
di: Sang Hyeon Ahn, et al.
Pubblicazione: (2025)

Patient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study
di: Chen Zhang, et al.
Pubblicazione: (2025)

Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)
di: Joaquim Mullol, et al.
Pubblicazione: (2026)

Impact of Sinus Surgery on Nasal Discharge in Chronic Rhinosinusitis: A Systematic Review and Meta‐Analysis
di: Ethan M. Kallenberger, et al.
Pubblicazione: (2025)

Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease
di: H. B. E. Elzinga, et al.
Pubblicazione: (2025)

Dupilumab Initiation for Surgically Refractory Chronic Rhinosinusitis With Nasal Polyps Is Associated With Differential Expression of CLC and Activation of Eicosanoid Pathways
di: Christina Dorismond, et al.
Pubblicazione: (2025)

Medicaid Coverage and Utilization for Novel Therapies for Chronic Rhinosinusitis With Nasal Polyposis
di: Eric R. Ramos, et al.
Pubblicazione: (2026)

Associations Between Blood Eosinophil Surface Proteins and Clinical Traits in Severe Asthma and Chronic Rhinosinusitis With Nasal Polyposis
di: Emeline Delaunay, et al.
Pubblicazione: (2025)

Determinants of Medication Adherence to Budesonide Nasal Irrigation in Patients With Chronic Rhinosinusitis and Allergic Rhinitis
di: Clifford Jiajun He, et al.
Pubblicazione: (2025)

A Systematic Review of Multidimensional Predictors for Refractory Chronic Rhinosinusitis: Clinical, Systemic and Local Insights
di: Di Wu, et al.
Pubblicazione: (2025)

Artificial Intelligence‐Based Pathological Subtype Diagnosis of Nasal Polyps: A Multidimensional and Micro‐Visualization Study
di: Xin Luo, et al.
Pubblicazione: (2026)

Chronic Rhinosinusitis With Nasal Polyposis in EGPA: A Real‐Life Multidimensional Analysis Through Mepolizumab Dosing and Role of Adjunctive Endoscopic Sinus Surgery (ESS)
di: Bright Oworae Howardson, et al.
Pubblicazione: (2026)